IMVT
Price
$27.90
Change
-$0.81 (-2.82%)
Updated
Oct 14 closing price
Capitalization
6.92B
34 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$33.62
Change
+$0.27 (+0.81%)
Updated
Oct 14 closing price
Capitalization
26.71B
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs ROIV

IMVT vs ROIV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMVT vs. ROIV commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and ROIV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMVT with price predictions
Oct 14, 2026

IMVT in downward trend: 10-day moving average moved below 50-day moving average on September 10, 2026

The 10-day moving average for IMVT crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for IMVT entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +0.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMVT advanced for three days, in 207 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

IMVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.407) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. IMVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for ROIV with price predictions
Oct 14, 2026

ROIV in downward trend: 10-day moving average moved below 50-day moving average on October 05, 2026

The 10-day moving average for ROIV crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ROIV as a result. In 64 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for ROIV turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 40 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

ROIV moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for ROIV entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ROIV's RSI Oscillator exited the oversold zone, 22 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +0.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in 232 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ROIV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.313) is normal, around the industry mean (26.782). P/E Ratio (1.966) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. ROIV's P/S Ratio (3333.333) is slightly higher than the industry average of (437.542).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
IMVT vs ROIV: Fundamental Ratings
IMVT
ROIV
OUTLOOK RATING
1..100
5259
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
6117
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
6144
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (51) in the null industry is somewhat better than the same rating for ROIV (86). This means that IMVT’s stock grew somewhat faster than ROIV’s over the last 12 months.

ROIV's Profit vs Risk Rating (17) in the null industry is somewhat better than the same rating for IMVT (61). This means that ROIV’s stock grew somewhat faster than IMVT’s over the last 12 months.

ROIV's SMR Rating (92) in the null industry is in the same range as IMVT (98). This means that ROIV’s stock grew similarly to IMVT’s over the last 12 months.

ROIV's Price Growth Rating (44) in the null industry is in the same range as IMVT (61). This means that ROIV’s stock grew similarly to IMVT’s over the last 12 months.

ROIV's P/E Growth Rating (42) in the null industry is somewhat better than the same rating for IMVT (100). This means that ROIV’s stock grew somewhat faster than IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (IMVT: $27.90 vs. ROIV: $33.62)
Brand notoriety: IMVT and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 114% vs. ROIV: 62%
Market capitalization -- IMVT: $6.92B vs. ROIV: $26.71B
IMVT [@Biotechnology] is valued at $6.92B. ROIV’s [@Biotechnology] market capitalization is $26.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green while ROIV’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 3 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 3 bullish, 3 bearish.
  • ROIV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than ROIV.

Price Growth

IMVT (@Biotechnology) experienced а -12.92% price change this week, while ROIV (@Biotechnology) price change was -3.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.52%. For the same industry, the average monthly price growth was -19.04%, and the average quarterly price growth was -19.99%.

Reported Earning Dates

IMVT is expected to report earnings on Nov 18, 2026.

ROIV is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-8.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMVT
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO1.420.08
+5.95%
Evotec SE
GIB72.350.23
+0.32%
CGI
QURE20.97-0.31
-1.46%
uniQure NV
ECOR8.20-0.19
-2.26%
electroCore
DKI0.07-0.02
-21.12%
DarkIris Inc.

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-2.82%
ROIV - IMVT
63%
Loosely correlated
+0.81%
KURA - IMVT
53%
Loosely correlated
-2.24%
SYRE - IMVT
46%
Loosely correlated
-2.26%
LXEO - IMVT
45%
Loosely correlated
-4.01%
DYN - IMVT
45%
Loosely correlated
-1.70%
More